linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Lupin Ltd.
 
BSE Code 500257
ISIN Demat INE326A01037
Book Value 611.14
NSE Code LUPIN
Dividend Yield % 0.51
Market Cap 1071439.65
P/E 19.50
EPS 120.17
Face Value 2  
05-May-2026 Lupin gets USFDA’s nod for Glycerol Phenylbutyrat...
05-May-2026 Lupin informs about press release
22-Apr-2026 Lupin launches Dapagliflozin and Metformin Hydroc...
22-Apr-2026 Lupin inches up on launching Dapagliflozin and Me...
22-Apr-2026 Lupin informs about press release
20-Apr-2026 USFDA concludes inspection at Lupin’s USA manufac...
18-Apr-2026 Lupin incorporates wholly owned subsidiary in Tha...
18-Apr-2026 Lupin informs about inspection updates
11-Apr-2026 Lupin launches Dapagliflozin Tablets in US
11-Apr-2026 Lupin submits press release
08-Apr-2026 Lupin gets USFDA’s nod for Dapagliflozin and Metf...
08-Apr-2026 Lupin secures USFDA approval for Dapagliflozin ta...
08-Apr-2026 Lupin surges on securing USFDA approval for Dapag...
07-Apr-2026 Lupin gets Great Place To Work certification
07-Apr-2026 Lupin trades higher on the BSE
Page 1 of 7
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.